Inventor · disambiguated record
Andrei W. Konradi
Also filed as: ASHWELL SUSAN · KONRADI ANDREI · KONRADI ANDREI W · KONRADI ANDREI WILLIAM
88 granted patents·24 pending applications·962 citations·filing 1998–2024
99Inventor score
Files withELAN PHARM INC45CORTEXYME INC12WYETH CORP10VIVACE THERAPEUTICS INC9IMAGO PHARMACEUTICALS INC7
Top patents by PatentIndex Score
112 records- 0198US7049306B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.ELAN PHARM INC·Filed 2002·Granted May 23, 2006·90 cites·6 claims
- 0295US7378529B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2005·Granted May 27, 2008·24 cites·23 claims
- 0395US6492372B1Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Dec 10, 2002·49 cites·6 claims
- 0494US9517276B2Compositions and methods for conjugating activatable antibodiesCYTOMX THERAPEUTICS INC·Filed 2014·Granted Dec 13, 2016·24 cites·31 claims
- 0594US7427628B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2006·Granted Sep 23, 2008·23 cites·14 claims
- 0694US6583139B1Compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 2000·Granted Jun 24, 2003·56 cites·26 claims
- 0794US6479492B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Nov 12, 2002·41 cites·7 claims
- 0893US7008949B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsWYETH CORP·Filed 2003·Granted Mar 7, 2006·45 cites·16 claims
- 0993US6903088B2Compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Jun 7, 2005·31 cites·10 claims
- 1093US6794506B23-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Sep 21, 2004·30 cites·22 claims
- 1192US7026328B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsWYETH CORP·Filed 2003·Granted Apr 11, 2006·48 cites·18 claims
- 1292US7005433B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2003·Granted Feb 28, 2006·27 cites·9 claims
- 1392US6911439B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Jun 28, 2005·28 cites·11 claims
- 1491US10730826B2Ketone inhibitors of lysine gingipainCORTEXYME INC·Filed 2019·Granted Aug 4, 2020·3 cites·11 claims
- 1590US10676470B2Inhibitors of lysine gingipainCORTEXYME INC·Filed 2019·Granted Jun 9, 2020·2 cites·11 claims
- 1690US10301301B2Inhibitors of lysine gingipainCORTEXYME INC·Filed 2018·Granted May 28, 2019·7 cites·18 claims
- 1790US9988375B2Inhibitors of lysine gingipainCORTEXYME INC·Filed 2017·Granted Jun 5, 2018·7 cites·20 claims
- 1890US7135477B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2003·Granted Nov 14, 2006·28 cites·9 claims
- 1989US11420935B2Bicyclic compoundsVIVACE THERAPEUTICS INC·Filed 2020·Granted Aug 23, 2022·2 cites·5 claims
- 2089US9758473B2Inhibitors of lysine gingipainCORTEXYME INC·Filed 2015·Granted Sep 12, 2017·10 cites·24 claims
- 2188US11591322B2Certain chemical compositions and methods of use thereofALGEN BIOTECHNOLOGIES INC·Filed 2022·Granted Feb 28, 2023·2 cites·29 claims
- 2288US6689781B2Phenylalanine derivatives as alpha 4 integrin inhibitorsELAN PHARM INC·Filed 2001·Granted Feb 10, 2004·27 cites·9 claims
- 2387US7205310B2Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2005·Granted Apr 17, 2007·11 cites·19 claims
- 2487US6900179B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 2001·Granted May 31, 2005·16 cites·13 claims
- 2586US7335663B2Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2003·Granted Feb 26, 2008·19 cites·8 claims
- 2686US7229970B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2005·Granted Jun 12, 2007·2 cites·11 claims
- 2786US6586602B2Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 2002·Granted Jul 1, 2003·10 cites·13 claims
- 2886US6545003B1Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Apr 8, 2003·23 cites·7 claims
- 2985US11325884B2Ketone inhibitors of lysine gingipainCORTEXYME INC·Filed 2020·Granted May 10, 2022·1 cites·12 claims
- 3085US8030328B2Imidazolone phenylalanine derivativesELAN PHARM INC·Filed 2006·Granted Oct 4, 2011·10 cites·27 claims
- 3185US7973044B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2009·Granted Jul 5, 2011·4 cites·19 claims
- 3285US7820687B2Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2009·Granted Oct 26, 2010·10 cites·24 claims
- 3385US7452912B2Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2002·Granted Nov 18, 2008·19 cites·11 claims
- 3485US2025099606A1Compositions and methods for conjugating activatable antibodiesCYTOMX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3584US11059786B2Aminopyridine compounds and methods for the preparation and use thereofCORTEXYME INC·Filed 2019·Granted Jul 13, 2021·2 cites·23 claims
- 3684US8367836B2Pyridinone antagonists of alpha-4 integrinsELAN PHARM INC·Filed 2010·Granted Feb 5, 2013·8 cites·27 claims
- 3784US6492421B1Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Dec 10, 2002·52 cites·35 claims
- 3883US7320960B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2002·Granted Jan 22, 2008·5 cites·20 claims
- 3983US6525026B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Feb 25, 2003·9 cites·18 claims
- 4083US2025270162A1Ketone inhibitors of lysine gingipainLIGHTHOUSE PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4182US7579466B2Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2007·Granted Aug 25, 2009·4 cites·32 claims
- 4281US7968547B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2009·Granted Jun 28, 2011·2 cites·10 claims
- 4381US7538215B2Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2005·Granted May 26, 2009·2 cites·4 claims
- 4481US6489300B1Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 1998·Granted Dec 3, 2002·40 cites·22 claims
- 4580US7576101B2Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agentsELAN PHARM INC·Filed 2004·Granted Aug 18, 2009·13 cites·26 claims
- 4680US6953802B2Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2001·Granted Oct 11, 2005·13 cites·28 claims
- 4778US7291645B2Phenylalanine derivatives as alpha 4 integrin inhibitorsELAN PHARM INC·Filed 2003·Granted Nov 6, 2007·7 cites·6 claims
- 4877US7754712B2Bridged N-cyclic sulfonamido inhibitors of gamma secretaseELAN PHARM INC·Filed 2007·Granted Jul 13, 2010·2 cites·27 claims
- 4977US2022081427A1Inhibitors of jun n-terminal kinaseIMAGO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 5076US8268935B2Preparation of polymer conjugates of therapeutic, agricultural, and food additive compoundsKONRADI ANDREI W·Filed 2006·Granted Sep 18, 2012·2 cites·41 claims
Showing the top 50 of 112 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →